CRC CARE's philosophy is that commercialisation begins at the
start of the research.
Our commercialisation and utilisation plan covers:
- Business case planning in conjunction with
partners;
- Market segmentation in conjunction with
partners;
- International market access, primarily
through partners, but also directly;
- Critical mass and clustering of
capability;
- Targeted service / technology / product
configurations for licensing;
- National demonstration sites; and
- Seed / venture capital access for SMEs as
well as new ventures.
Investment by CRC CARE in its
research programs is based on the technical viability and
commercial value of the expected outputs, using financial and
technology evaluation tools.
From the start, CRC CARE has
embedded commercialisation, and business opportunity analysis and
harvesting in every stage of its research and business process.
This enables effective delivery of research value creation
opportunities to stakeholders as well as helping to manage
Australia's environment in a more cost effective fashion. The CRC
engages technology incubation and investment capital providers as
partners, to assist in the formation of new environmental
technology enterprises.
Key elements in the strategy include:
- Program planning and project identification
with industry partners;
- Value propositions with full opportunity
assessment for all projects;
- Specialist management for business
development and commercialisation;
- Research programs with performance
management and milestones at all stages;
- Maximising value delivery from research
outcomes through: IP harvesting by industry partners (with
preferential rights) for direct adoption; commercialisation
companies; spin-offs and start-ups; and ventures with third parties
in global markets;
- Alliance management to develop strategic
links into global markets;
- Participation in international standards
setting, seeking opportunities to lock in our technology; and
- Industry cluster development, with direct
involvement of small to medium enterprises.